Get to know 3D-Side
3D-Side is a Belgian company spin-off from the UCLouvain University, having developed first class products in cranioplasty and bone tumor surgery for more than 10 years. Based on this internal know-how, 3D-Side has developed a very specific vision on integrated surgical software.
Through this vision, an innovative platform named Customize has been developed for our own use connecting surgeons, patients, and medical device companies to optimize and streamline communication, creation and supervision of the production of patient-specific medical devices.
Since 2018, 3D-Side provides this in-house developed technology to external medical device companies.
3D-Side S.A. is committed to provide an innovative platform connecting doctors, patients & medical companies allowing to communicate, create and supervise the production of patient-specific medical devices.
Cover a large panel of surgical and medical applications.
Become the must-have platform software in surgery planning.
3D-Side provides medical companies with Customize, a web platform to efficiently market custom made devices. From images to 3D printing, it consists of advanced tools for planning, communication with the medical team and manufacturing of patient specific medical devices (PSMD) :
Interact to communicate easily with doctors
Create to design custom-made instruments/implants
Supervise to manage quality and just-in-time manufacturing.
3D-Side: a software company. Customize has been built over years by the 3D-Side team for other medical companies. It is then fully customizable to our customers' needs.
3D-Side: a medtech company. 3D-Side markets two major products based on our software, additive manufacturing technology and a strong knowledge in surgical field: custom cranial implants and patient-specific instruments (PSI) for complex bone surgery. Our team has an extended expertise in patient specific medical device design, technical files (EU/FDA), validations, … We can assist you with the technical and regulatory sides and also as OEM for the design of PSMD.
3D-Side: a medical 3D printing company. 3D-Side has an integrated manufacturing set-up for PSI. This ISO13485 workflow is available for our customers.
Board of directors
Laurent PAUL holds a PhD in biomedical sciences from UCLouvain. During his thesis, he developed computerized tools to assist surgeons during bone tumor resection. In 2013 Laurent founded Visyos, a spin-off company, dedicating its focus to the launch of guides for bone tumors on the EU market.
At 3D-Side Laurent is the expert in medical software, IT/image processing for both patient-specific field and AI-based segmentation and is responsible for the supervision of all the 3D-Side Platform (Customize). Laurent also holds an MBA from the Louvain School of Management, he is also the author and co-author of multiple publications.
Khanh TRAN DUY is a mechanical engineer and holds a PhD in applied Sciences.
During his PhD in maxillo-facial surgery, Khanh launched multiple projects at university, including raising funding for multi-million euros and was involved in other start-up projects such as Corquest – acquired by Ceyliad. In 2011 he founded his very own company, Centis engineering.
At 3D-Side Khanh is responsible for the neurosurgical device side of activities, he is in charge of Business Development, as well as supervising quality. Khanh also holds a MSc in Business Administration he is also the author and co-author of multiple patents.
Prior to joining Inventures in 2017, Laurent Jouret was a Senior Investment Manager at Sofina, a listed financial holding company based in Belgium, with more than €5 billion under management. He was a member of the internal Committees supervising direct investment opportunities and was regularly involved in the sourcing, analysis and negotiation of these investments.
Laurent holds a Business Engineering Master’s degree from the Louvain School of Management and is a Certified European Financial Analyst (BVFA-ABAF). In 2013, he completed the Private Equity and Venture Capital program at Harvard Business School and, in 2011, the Emerging Leader Program at London Business School.
Mr. Guido Van der Schueren is majority shareholder and Chairman of the Board of, amongst others, HYBRID Software, Global Graphics (Euronext: GLOG:BB) and Brand Quadergy. HYBRID Software is active in the development of prepress editing, and production & collaboration for the graphics arts industry, more specifically labels and packaging. Global Graphics is active as supplier of printhead driver electronics for industrial inkjet presses and software platforms for digital printing. Brand Quadergy is a European midsized design & prepress service agency.
Until 2007 Guido Van der Schueren was Managing Director of Artwork Systems, which he co-founded. Until mid-2011 he was Chief Commercial Officer and later Vice Chairman of the Board of Esko Artwork.
Bringing smart investors and daring entrepreneurs together. Extensive and successful CFO working experience in Mid Cap listed companies with robust investor relations achievements within the European and American investment community, focusing on creating added value and building relevant network contacts.
Corporate Secretary / Private Equity/ Interim management/ Corporate Governance /Corporate Social Responsibility and Social Responsible Investment
Senior Investment Manager
at TheClubDeal SA
Jean-Marie Berger is an entrepreneur with more than 20 years of experience in the orthopedics segment of the medical device industry. He managed two companies to successful exits (Shoulder in Motion Inc, Integrated Shoulder Collaboration Inc). Prior becoming an entrepreneur , he held various marketing and commercial executive positions in Tornier/Wright Medical Group including VP of Product Delivery - Upper Extremity and General Manager of Tornier Canada
Jean-Marie has a degree in Marketing and International Business from the Grenoble Ecole of Management and has completed his executive MBA at the University of Minnesota in 2011.
3D-Side’s mission is to help our clients contribute to the United Nation sustainable goals (Goal 3. Target 3.4) by providing them Customize.
SDG 3.4: “By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being”